NCT03352843View on ClinicalTrials.gov

Single Low-dose Primaquine Efficacy and Safety.

PHASE4CompletedINTERVENTIONAL

Enrollment

157

Participants

Timeline

Start Date

June 11, 2019

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions

Malaria

Interventions

DRUG

Primaquine

All patients will be administered with a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen, and then followed-up for 28 days for clinical and laboratory assessment to assess safety and efficacy.

Trial Locations (1)

Unknown

Tropical Pesticides Research Institute (TPRI), Arusha

All Listed Sponsors

collaborator

European and Developing Countries Clinical Trials Partnership (EDCTP)

OTHER_GOV

lead

Tropical Pesticides Research Institute, Tanzania

OTHER_GOV

NCT03352843 - Single Low-dose Primaquine Efficacy and Safety. | Biotech Hunter | Biotech Hunter